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The HEART Camp Exercise Intervention Improves Exercise
Adherence, Physical Function, and Patient-Reported Outcomes in
Adults With Preserved Ejection Fraction Heart Failure
WINDY W. ALONSO, PhD, RN, FHFSA,1 KEVIN A. KUPZYK, PhD,1 JOSEPH F. NORMAN, PhD, PT,2 SCOTT W. LUNDGREN, DO,3
ALFRED FISHER, MD, PhD,4 MERRY L. LINDSEY, PhD,5,6 STEVEN J. KETEYIAN, PhD,7 AND
BUNNY J. POZEHL, PhD, APRN-NP, FHFSA, FAHA, FAAN1
Omaha, Nebraska; and Detroit, Michigan

ABSTRACT
Background: Despite exercise being one of few strategies to improve outcomes for individuals with heart
failure with preserved ejection fraction (HFpEF), exercise clinical trials in HFpEF are plagued by poor
interventional adherence. Over the last 2 decades, our research team has developed, tested, and
refined Heart failure Exercise And Resistance Training (HEART) Camp, a multicomponent behavioral
intervention to promote adherence to exercise in HF. We evaluated the effects of this intervention designed
to promote adherence to exercise in HF focusing on subgroups of participants with HFpEF and heart failure
with reduced ejection fraction (HFrEF).
Methods and Results: This randomized controlled trial included 204 adults with stable, chronic HF. Of
those enrolled, 59 had HFpEF and 145 had HFrEF. We tested adherence to exercise (defined as 120
minutes of moderate-intensity [40% 80% of heart rate reserve] exercise per week validated with a heart
rate monitor) at 6, 12, and 18 months. We also tested intervention effects on symptoms (Patient-Reported
Outcomes Measurement Information System-29 and dyspnea-fatigue index), HF-related health status (Kansas City Cardiomyopathy Questionnaire), and physical function (6-minute walk test). Participants with
HFpEF (n = 59) were a mean of 64.6 § 9.3 years old, 54% male, and 46% non-White with a mean ejection
fraction of 55 § 6%. Participants with HFpEF in the HEART Camp intervention group had significantly
greater adherence compared with enhanced usual care at both 12 (43% vs 14%, phi = 0.32, medium effect)
and 18 months (56% vs 0%, phi = 0.67, large effect). HEART Camp significantly improved walking distance on the 6-minute walk test (h2 = 0.13, large effect) and the Kansas City Cardiomyopathy Questionnaire
overall (h2 = 0.09, medium effect), clinical summary (h2 = 0.16, large effect), and total symptom (h2 = 0.14,
large effect) scores. In the HFrEF subgroup, only patient-reported anxiety improved significantly in the
intervention group.
Conclusions: A multicomponent, behavioral intervention is associated with improvements in long-term
adherence to exercise, physical function, and patient-reported outcomes in adults with HFpEF and anxiety
in HFrEF. Our results provide a strong rationale for a large HFpEF clinical trial to validate these findings
and examine interventional mechanisms and delivery modes that may further promote adherence and
improve clinical outcomes in this population.
Clinical Trial Registration: : URL: https://clinicaltrials.gov/. Unique identifier: NCT01658670 (J Cardiac Fail 2021;00:1 11)
Key Words: Heart failure, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, exercise, adherence.
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Bullet Points
 Adults with heart failure with preserved ejection fraction (defined as an ejection fraction of 50%) responded
favorably to the Heart Failure Exercise and Resistance
Training (HEART) Camp.
 The HEART Camp intervention promotes adherence to
exercise in adults with HFpEF compared with paid access
to a fitness center alone.
 The HEART Camp intervention improved physical
function, health status, and symptoms in adults with failure
with preserved ejection fraction over time compared with
paid access to a fitness center alone.
Lay Summary
Heart Failure Exercise and Resistance Training
(HEART) Camp is an exercise intervention that was previously successful at improving adherence to exercise in
adults with heart failure. In this study, we divided the
HEART Camp trial participants based on their ejection fraction into preserved ejection fraction (50%) and reduced
ejection fraction (<50%) subgroups to see how the subgroups responded to the intervention compared with counterparts who were given only paid access to a fitness center.
Adults with heart failure with preserved fraction significantly improved their exercise adherence with the HEART
Camp intervention compared with a group receiving only
access to a fitness center.
Visual Take Home Graphic

Proposed Tweet
The multicomponent HEART Camp exercise coaching
intervention promotes long-term adherence to exercise in
adults with heart failure with preserved ejection fraction.
#HeartFailure #HFpEF #ExerciseAdherence

Exercise is one of few successful strategies to improve outcomes in adults with heart failure with preserved ejection fraction (HFpEF). Yet, few adults with HF successfully meet the
Heart Failure Society of America exercise guidelines that recommend 30 minutes of supervised moderate intensity exercise
5 days per week and long-term adherence to exercise interventions remains a challenge.1,2 Cardiac rehabilitation has been
the predominant model of exercise for adults with cardiovascular disease and heart failure; however, Medicare reimbursement is limited to those with an ejection fraction of less than
35% (heart failure with reduced ejection fraction [HFrEF]),
which fails to account for half of the HF population, and cardiac rehabilitation is notoriously underused by those adults
with HF who are eligible.3,4
Several exercise clinical trials have targeted adults with
HFpEF and HFrEF.5 14 The majority of these studies examined
short-term effects (4 20 weeks) of exercise on physiologic
changes such as peak oxygen uptake.5 9,11 13 Most of these trials do report efficacy in improving physiologic measures with
the exercise interventions, including aerobic, resistance, and/or
high-intensity interval training, but few report adherence outcomes and no studies to date have resulted in significant
improvements in mortality or hospitalizations. Further, few
studies included patient-reported outcomes and, in those that
did, only quality of life6,10,12 and depression13 were reported.
Quality-of-life improvements were reported in some but not all
studies and it was unclear if improvements were sustained.
Recent findings from the Rehabilitation Therapy in Older
Acute Heart Failure Patients (REHAB-HF) trial, which

recruited participants during a hospitalization for acute HF
to attend 1-on-1 exercise training sessions that began during
the hospital admission to 12 weeks, were promsing.15
Adherence to exercise was reported as high as 76% during
the intervention and 78% at the 3-month follow-up.14 However, adherence during the 12-week intervention period was
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measured by session attendance only and by patient selfreport at the 3-month follow-up.14
Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure (Optimex-Clin)10 is the
only completed trial to date to recruit a HFpEF-only sample
and examine long-term (12-month) exercise outcomes.
Optimex-Clin randomized participants to high-intensity
interval training, moderate intensity continuous training,
and a control group that received only a guideline-based
recommendation to exercise. Nonsignificant differences in
the primary end point, namely, peak oxygen uptake at 3
months, were noted.10 Adherence to Optimex-Clin at 12
months, measured as session attendance, was modest in
both the moderate intensity continuous training and highintensity interval training groups,10 but proportionally
higher when compared with adherence reported in 2 prior
exercise clinical trials in HF: (a) the seminal, multicenter
trial, Heart Failure A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) (34% adherence)16 and (b) prior work of this research team (42%
adherence).17 The dose-dependent response associated with
exercise is difficult to achieve and maintain when participants are nonadherent to exercise.18 20
Our team developed and tested the multicomponent Heart
failure Exercise and Resistance Training (HEART) Camp
behavioral intervention to promote long-term adherence to
exercise in adults with HF.21 We defined adherence as
achieving 120 or more minutes of moderate intensity exercise per week validated with a heart rate monitor. The
HEART Camp intervention group achieved significantly
better long-term adherence at 12 months (42%) and 18
months (35%) compared with enhanced usual care (28%
and 19% adherence, respectively) in a mixed sample of
adults with HFpEF and HFrEF.22 The effects on adherence
were moderated by the ejection fraction; those with higher
ejection fractions at baseline achieved better long-term
adherence. The HEART Camp also significantly improved
physical function, quality of life, and depression.23
HF-ACTION (n = 2331) reported safety and efficacy of
exercise in HF with reduced ejection fraction (HFrEF); however, participants with HFpEF were excluded.16 A similar trial
in HFpEF has not been reported. Our knowledge of successful
interventional strategies to initiate and sustain exercise in HF,
particularly in HFpEF, remains limited. Therefore, the purpose
of this secondary data analysis is to evaluate the effects of the
multicomponent, HEART Camp on adherence with exercise
recommendations in the HFpEF and HFrEF subgroups as
compared with enhanced usual care.

and 18 months). Details of the study protocol and the results
were published previously.21 23 In brief, after enrollment
and completion of a cardiopulmonary exercise test, all participants took part in a minimum of 6 scheduled, supervised
exercise sessions in cardiac rehabilitation before randomization. During prerandomization exercise training sessions,
participants learned moderate-intensity continuous training
(40% 80% heart rate reserve)22,24 and resistance training
(10 15 repetitions to volitional fatigue).25,26 The safety of
all participants was ensured and plans for participant supervision were outlined clearly in the study protocol. Participants who completed these sessions were then randomized
with stratification by study site and sex to 2 groups
(HEART Camp or enhanced usual care). After randomization, all participants, including those randomized to
enhanced usual care, received standard care for heart failure
and were given paid access to a hospital-based exercise
training facility where they could exercise independently
for 18 months. This paid access was considered an enhancement beyond the standard care of individuals with HF and
eliminated a potential financial barrier for participants. Participants randomized to the HEART Camp group received
the HEART Camp intervention, which is described in
greater detail elsewhere in this article.
Setting and Sample for the Parent Study

The HEART Camp study team recruited 204 participants
from 2 urban medical centers: Bryan Heart Institute in Lincoln, Nebraska, and Henry Ford Hospital in Detroit, Michigan. Inclusion and exclusion criteria are shown in Table 1.
All participants provided written informed consent and the
institutional review board at each site approved the study
and provided oversight. The CONSORT diagram with
screening and randomization details has been published previously.22 Randomization was stratified by site and sex.
Sample for the Subgroup Analyses

Recently, the Heart Failure Society of America, the Heart
Failure Association of the European Society of Cardiology,
and the Japanese Heart Failure Society published a universal definition of HF.27 The new guideline suggests classification of HF on the basis of ejection fraction; individuals
with an ejection fraction of 50% or more are classified as
HFpEF.27 We applied this classification to identify our subgroups for this post hoc analysis: HFpEF (EF of 50%,
n = 59) and HFrEF (EF of <50%, n = 145).
HEART Camp Intervention

Methods
Design

The parent HEART Camp study was a 2-site, prospective, randomized 2-group repeated measures experimental
design. Data were collected at 4 timepoints (baseline, 6, 12

The HEART Camp is a theory-driven, multicomponent
intervention that focuses on participants’ knowledge, attitudes, self-efficacy, self-management skills, and social support. The intervention took place over 3 phases, adoption
(baseline to 6 months), transition (months 7 12) and maintenance (months 13 18). During the adoption and
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Table 1. Inclusion and Exclusion Criteria for the HEART Camp Clinical Trial
Inclusion Criteria

Exclusion Criteria

1 Diagnosis of systolic, diastolic, or combined chronic HF
(stage C confirmed by echocardiography and clinical evaluation)

1 Clinical evidence of decompensated HF

2 19 years of age or greater
3 Able to speak and read English
4 Telephone access in home
5 Stable pharmacologic therapy per guidelines for past 30 days

2 Unstable angina pectoris
3 Myocardial infarction, coronary artery bypass surgery, or biventricular
pacemaker < 6 weeks prior
4 Orthopedic or neuromuscular disorders preventing participation in aerobic exercise and strength/resistance training
5 Participation in 3 times per week aerobic exercise in the past 8 weeks
6 Cardiopulmonary exercise test results that precluded safe exercise
training
7 Plans to move more than 50 miles from the exercise site within the next
year
8 Peak oxygen uptake in females >21 mL/kg/min and in males >24 mL/
kg/min
9 Pregnancy planned or current

HEART, Heart failure Exercise And Resistance Training; HF, heart failure.

transition phases, the intervention included individualized,
weekly coaching with an exercise coach, where coaches
and participants discussed goals, self-monitoring, relapse
prevention, and self-management strategies. During the
maintenance phase, face-to-face interaction between participants and coaches was stopped and participants were
expected to self-manage their exercise. A detailed interventional protocol was published in 2014.21
Data Collection and Measurement Tools

Baseline measures included demographic information (age,
race, sex, and marital status) and clinical information (body
mass index, left ventricular ejection fraction, and New York
Heart Association functional class). Adherence to exercise
(primary outcome) was calculated based on confirmed minutes
of exercise per week. Participants achieving 120 or more
minutes of moderate intensity exercise per week or more
(80% of the Heart Failure Society of America recommended
150 minutes per week) were considered adherent. Minutes of
exercise were collected using self-report diaries (collected
weekly in the HEART Camp group and every 2 months in the
enhanced usual care group) and validated using a heart rate
monitor (Polar Electro Inco, Lake Success, NY). In designing
our study, we elected to collect adherence data from participants in the enhanced usual care group every 2 months to
avoid interventional effects from data collection. We preprogrammed the heart rate monitor with an individualized, target
heart rate range that was determined based on results from
each participant’s cardiopulmonary exercise test and corresponded with 40% 80% of their heart rate reserve. Participants were instructed to wear the heart rate monitor during all
exercise sessions and stay within the prescribed target heart
rate range. We downloaded data into the Polar Pro Trainer,

which provides details on date, time spent in exercise, average
HR, and amount of exercise time within the target range. Any
exercise minutes below the 40% heart rate reserve were not
counted as minutes of exercise. Adherence levels for 6, 12,
and 18 months were computed as the averages across the 4
weeks before each measurement time point. Participants
achieving 120 or more minutes of moderate intensity exercise
per week on average over this 4-week period were considered
adherent at the given time point.
Secondary outcomes were tested at baseline, 6, 12, and
18 months and included objective physical function (6-Minute Walk Test [6MWT]) and patient-reported health status
(Kansas City Cardiomyopathy Questionnaire [KCCQ]),
anxiety, depression, role satisfaction, fatigue, pain interference, physical function, and sleep disturbance (PatientReported Outcomes Measurement Information System
[PROMIS]-29). Each of these is metrics described in brief.
The 6MWT28 is an objective measure of physical function performed to assess the exercise capacity of individuals
with HF.29 During this self-paced test, which has been standardized through guidelines provided by the American Thoracic Society,28 participants walk on a flat, 100-foot
walkway while research personnel measure the distance in
meters walked in 6 minutes. In the HEART Camp study,
participants were asked at baseline, 6, 12, and 18 months to
complete two 6MWTs 7 days apart. The farthest distance
walked between these 2 tests was recorded as the 6MWT
measurement for that time point.
The KCCQ is a 23-item, HF-specific tool that measures 5
domains (physical limitation, symptoms, self-efficacy, quality
of life, and social limitation) and generates 3 summary scores
(overall summary score, clinical summary score, and total
symptom score).30 The KCCQ is commonly used in HF clinical trials and was recently recommended as an important
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quality indicator by the 2020 American College of Cardiology/American Heart Association Task Force on Performance
Measures.31 Overall summary scores that change by 5 points
or greater over time are considered clinically meaningful.32
The KCCQ has been validated in adults with HFpEF.33
The PROMIS-29 uses 29 items to measure 7 domains,
including anxiety, depression, role satisfaction, fatigue,
pain interference, physical function, and sleep disturbance.
PROMIS tools were developed by Cella et al34 to capture
patient-reported outcomes. These measures have been validated in the HF population.35,36
Statistical Analyses

All statistical methods were applied across both the HFpEF
and HFrEF subgroups. Descriptive statistics were calculated on
all demographic and dependent variables. Data were compared
between HEART Camp and enhanced usual care groups as
well as HFpEF and HFrEF groups using t tests and x2 analyses
as appropriate. To assess adherence between groups at 18
months (primary aim), a x2 test was used to test group differences in the proportion of the sample that adhered to at least 80%
of the 150 minutes per week recommendation. Tests were carried out at 6, 12, and 18 months, the primary data collection
points in the study. A Fisher’s exact test was completed for any
time point with fewer than 5 participants in either group. The
analysis included all participants according to the condition to
which they were assigned and was based on all available data.
(No data imputation was performed.) Missing data were
assessed before analyses and our missing data rate is 18%.
Analysis of variance tests were completed to calculate
effect sizes, reported as h2, for secondary outcomes. To assess

group differences in change over time on continuous outcomes, linear mixed models were performed for each dependent variable. Significant Time £ Group interactions indicate
significant differences in change over time between the HC
and enhanced usual care groups. Variables were examined for
normality by examining skew and kurtosis values. Although
the PROMIS measures were distributed normally, the 6MWT
and KCCQ variables were negatively skewed. Square transforms (or second power transforms) were effective in normalizing the distributions. SPSS version 25 was used for data
management and descriptive statistics and SAS 9.4 was used
for linear mixed models. Time was treated as a categorical variable because all intervals between time points and across participants were equal. Before assessing fixed effects, the most
appropriate covariance structure was determined by performing models with various structures (eg, variance components,
unstructured, Toeplitz, autoregressive) and comparing fit statistics. In the even that all fit statistics did not agree on the best
error structure, preference was given to the more parsimonious
structure. Additional models were performed to examine the
effect of covariates (age, sex, body mass index, and race
[White vs non-White]) on intervention effects in both subgroups. Statistical significance was set at the alpha 0.05 level.
Results
The parent study enrolled 204 adults with stable chronic
HF. Fifty-nine (29%) of these participants had an ejection
fraction of 50% or greater (HFpEf subgroup) and 145 had
an EF of less than 50% (HFrEF subgroup). The characteristics of the HFpEF and HFrEF subgroups are presented in
Table 2. Participant characteristics were balanced between

Table 2. Participant Demographic and Clinical Variables
HFpEF Subgroup

Demographic
variables
Age, mean (SD)
Female sex, n (%)
Married, n (%)
Non-Caucasian, n (%)
Clinical variables
Ejection fraction,
mean (SD)
NYHA class, n (%)
I
II
III
IV
Beta blocker, n (%)
ACE/ARB, n (%)
BMI, mean (SD)
pVO2 from cardiopulmonary exercise
test

HFrEF Subgroup

HEART Camp
(n = 25)

Enhanced Usual
Care (n = 34)

63.3 (9.4)
11 (44%)
18 (72%)
11 (44%)

65.6 (9.3)
16 (47.1%)
20 (58.8%)
16 (47.1%)

.367
.816
.296
.816

58.6 (13.3)
34 (44.2%)
34 (44.2%)
40 (51.9%)

58.6 (10.1)
30 (44.1%)
41 (60.3%)
28 (41.2%)

.987
.996
.052
.195

54.2 (5.7)

55.7 (6.4)

.365

34.4 (9.3)

32.9 (10)

.344

3 (12%)
14 (56%)
8 (32%)
0
23 (92%)
20 (80%)
35.6 (7.2)
15.6 (4.1)

3 (8.8%)
18 (52.9%)
13 (38.2%)
0
32 (94.1%)
28 (82.4%)
36.4 (8)
15 (4.5)

.850

2 (12%)
40 (56%)
34 (32%)
1 (1.3%)
76 (98.7%)
72 (93.5%)
34.7 (9.0)
14.6 (4.0)

8 (8.8%)
41 (52.9%)
18 (38.2%)
1 (1.5%)
68 (100%)
55 (80.9%)
33.9 (7.6)
15.7 (3.6)

.046

P Value

.749
.819
.708
.662

HEART Camp
(n = 77)

Enhanced Usual
Care (n = 68)

P Value

.346
.021
.532
.099

ACE, angiotensin-converting enzyme Inhibitor; ARB, angiotensin-receptor blocker; BMI, body mass index; HEART, Heart
failure Exercise And Resistance Training; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; NYHA,
New York Heart Association functional class; pVO2, peak oxygen consumption; SD, standard deviation.
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intervention and enhanced usual care groups in both the
HFpEF and the HFrEF subgroups. Demographic and clinical variables were compared between the HFpEF and
HFrEF subgroups. We found HFpEF participants were significantly older (P = .001) and less likely to be taking a beta
blocker (P = .025) compared with HFrEF counterparts.
There were no significant differences between the HFpEF
and HFrEF subgroups on sex, race, marital status, body
mass index, New York Heart Association functional class,
or peak oxygen consumption.
In the HFpEF subgroup (n = 59), 54% identified as men.
Ages ranged from 37 to 85 years (mean 64.6 § 9.3 years)
and the ejection fraction ranged from 50% to 76% in this
subgroup with a mean of 55 § 6%. Of the 27 non-Caucasian
participants (45.8% of the sample), 25 were African American. In the HFrEF subgroup (n = 145), 81 (56%) identified
as men and 64 (44%) as women. HFrEF participants were a
mean age of 58.6 § 11.9 years. Ejection fraction ranged
from 12% to 49% in this subgroup with a mean of 33.7 §
9.6%. Of the 68 non-Caucasian participants, 66 were African American. Adherence data are shown in Fig. 1a and 1b.
Among patients with HFpEF in the HEART Camp group,
adherence at both 12 months (42%) and 18 months (56%)
was significantly greater compared with the enhanced usual
care group (14% and 0%, respectively). At the 6-month
time point, adherence was 42% in the HEART Camp group
and 19% in the enhanced usual care group; this difference
was not statistically significant. Among patients with
HFrEF in the HEART Camp group, adherence at 6 months
(36%), 12 months (42%), and 18 months (29%) was not significantly greater compared with the enhanced usual care
group (38%, 34%, and 29%, respectively).
Participants with HFpEF in the HEART Camp group
walked further during the 6MWT than enhanced usual care
participants at all times points, including baseline, with the
difference reaching significance at 18 months (Table 3).
Distance in the HEART Camp group increased by 63.25 m
compared with 13.16 m in the enhanced usual care group
between baseline and 18 months, F(2.7,73.1) = 4.14,
P = .011; h2 = 0.13, large effect. In a hierarchical linear
model, the Time £ Group interaction for 6MWT distance
was significant, as shown in Table 4, indicating that the
groups differed significantly in change over time.
We identified significant differences between adults with
HFpEF in HEART Camp and enhanced usual care on the
KCCQ Overall Summary Score, F(3,96) = 3.42, P = .02;
h2 = 0.09, medium effect; the Clinical Summary Score, F
(3,95) = 6.17, P = .001; h2 = 0.16, large effect; and Total
Symptom Score, F(2.7,85.3) = 5.31, P = .003; h2 = 0.14, large
effect. Between-group comparisons of overall change
(Time £ Group interactions) for the Dyspnea-Fatigue Inventory and domains of the PROMIS-29 were nonsignificant in
hierarchical linear models. Results from all hierarchical linear
models of data for the 6MWT, KCCQ, Dyspnea-Fatigue
Inventory, and PROMIS-29 are reported in Table 4. We report
means by group over time in Fig. 2a c for those scores with
significant Time £ Group interactions.

a

b

Fig. 1. (A) Longitudinal adherence to exercise in adults with heart
failure with preserved ejection fraction (HFpEF) from the Heart
failure Exercise And Resistance Training (HEART) Camp clinical trial
using all available data. This figure demonstrates adherence for participants that completed data collection at each time point in the HFpEF
subgroup. In the HEART Camp group, at 6 months, 9 of 21 (42%)
were adherent to exercise, at 12 months, 9 of 21 (42%) were adherent,
and at 18 months 9 of 16 (56%) were adherent to exercise. In the EUC
group, at 6 months, 6 of 31 (19%) were adherent to exercise, at 12
months, 4 of 28 (14%) were adherent, and at 18 months 0 of 28 (0%)
were adherent to exercise. *a = 0.05. (B) Longitudinal adherence to
exercise in adults with heart failure with reduced ejection fraction
(HFrEF) from the HEART Camp clinical trial using all available data.
This figure demonstrates adherence for participants that completed
data collection at each time point in the HFrEF subgroup. In the
HEART Camp group, at 6 months, 26 of 73(36%) were adherent to
exercise, at 12 months, 28 of 67 (42%) were adherent, and at 18
months 16 of 55 (29%) were adherent to exercise. In the EUC group,
at 6 months, 24 of 64 (38%) were adherent to exercise, at 12 months,
21 of 62 (34%) were adherent, and at 18 months 17 of 60 (29%) were
adherent to exercise. Note: Adherence based on 120 minutes of moderate intensity or more of exercise per week. EUC, enhanced usual care
(received paid access to an exercise facility).

In participants with HFpEF, the rate of attrition at the
end of the 18-month study was 25.4%, with 44 participants
completing heart rate validation and exercise diaries at 18
months. We had slightly greater attrition (32.2%) with
study instruments; 40 of 59 participants completed all data
points. The differences in attrition rates between groups
was nonsignificant at all time points. Interestingly, when
noncompleters were examined against completers on our
measurement tools, the only difference we found in baseline measures was on the PROMIS-Sleep Disturbance.
Completers had significantly lower scores (47.5) on the
domain than noncompleters (54.8), t(57) = 2.65, P = .01,

Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by
Elsevier on October 18, 2021. For personal use only. No other uses without permission. Copyright ©2021. Elsevier Inc. All rights reserved.

ARTICLE IN PRESS
The HEART Camp Exercise Intervention Improves Exercise Adherence, Physical  Alonso et al 7
Table 3. Six-Minute Walk Test Distance Over Time for Participants With HFpEF
Group

Baseline

6 months

12 months

18 months

HEART Camp, mean (SD)
Enhanced usual care, mean (SD)
t test P value

383.61 (117.63)
359.45 (101.46)
.402

411.21 (120.89)
370.98 (109.94)
.241

406.52 (140.94)
368.86 (118.11)
.346

446.86 (112.71)
372.61 (95.55)
.048

HEART, Heart failure Exercise And Resistance Training; HFpEF, heart failure with preserved ejection fraction; SD, standard deviation.
Bold font indicates statistical significance a=.05.

Table 4. Hierarchical Linear Models of Physical Function, Heart Failure-related Health Status, and Patient-Reported Symptoms in
Participants with HFpEF

Six-minute walk test*
KCCQ overall summary score
KCCQ clinical summary score
KCCQ total symptom score
KCCQ quality of life
Dyspnea-fatigue inventory
PROMIS anxiety
PROMIS depression
PROMIS social satisfaction with roles
PROMIS fatigue
PROMIS Pain interference*
PROMIS physical function
PROMIS sleep disturbance*

Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group
Time
Group
Time £ Group

Num DF

Den DF

F

P Value

3
1
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
3

89
58
89
130
57
130
131
57
131
131
57
131
131
57
131
131
57
131
131
55
131
130
57
130
131
57
131
132
58
132
91
58
91
130
57
130
97
59
97

3.584
2.928
5.718
0.595
0.062
3.981
0.742
0.014
5.698
0.647
0.006
4.179
1.123
0.354
2.518
2.063
0.419
0.602
0.639
2.044
1.019
1.371
1.266
1.347
1.304
0.209
1.877
0.891
0.276
2.267
1.623
0.270
0.264
2.133
0.538
0.241
1.433
0.296
1.853

.017
.092
.001
.619
.805
.009
.529
.906
.001
.586
.939
.007
.342
.554
.061
.108
.520
.615
.591
.158
.386
.255
.265
.262
.276
.650
.137
.448
.602
.084
.190
.605
.851
.099
.466
.868
.238
.588
.143

HFpEF, heart failure with preserved ejection fraction; KCCQ, Kansas City Cardiomyopathy Questionnaire; PROMIS, Patient-Reported Outcomes Measurement Information System.
Bold font indicates statistical significance a=.05.
*An Autoregressive covariance structure; otherwise, a variance components structure.

indicating that noncompleters had greater sleep disturbance. A sensitivity analysis completed with all data from
the parent HEART Camp study (previously reported)
found no differences in findings as a result of excluding
participants that did not complete the study.22 In the current study, we completed a sensitivity analysis in the
HFpEF subgroup, again with no changes in outcomes.
This finding indicates that attrition did not bias outcomes
or dilute significant findings.

All primary analyses were performed with the HFrEF
subgroup. As mentioned elsewhere I this article, adherence did not differ significantly at any time point. Of the
13 outcome variables, only the PROMIS-Anxiety differed significantly over time (significant Time £ Group
interaction). PROMIS-Anxiety improved for the
HEART Camp group, whereas anxiety increased in the
enhanced usual care group. Otherwise, no differences
were observed in the HFrEF subgroup.
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Fig. 2. (A) Kansas City Cardiomyopathy Questionnaire (KCCQ)
Overall Summary Score. This figure shows the mean KCCQ overall
summary scores in the heart failure with preserved ejection fraction
(HFpEF) subgroup from baseline to 18 months. Analysis of variance
(ANOVA) indicated a statistically significant change by group over
time, F(3,96) = 3.4, P = .02. (B) KCCQ clinical summary score. This
figure shows the mean KCCQ clinical summary scores in the HFpEF
subgroup from baseline to 18 months. ANOVA indicated a statistically
significant change by group over time, F(3,95) = 6.2, P = .01. (C)
KCCQ Total Symptom Score. This figure shows the mean KCCQ total
symptom scores in the HFpEF subgroup from baseline to 18 months.
ANOVA indicated a statistically significant change by group over time
F(2.7,85.3) = 5.3, P = .003.

To examine the effect of covariates in the models testing intervention effects in both subgroups, we added age, sex, body mass
index, and race (White vs non-White) as covariates. Although
these covariates were significant in some cases, there was no
change in the significance of the Time £ Group interaction in
any of the models. Because the effectiveness of the intervention
was not altered by the addition of the covariates, we reported the
unadjusted models in the interest of model parsimony.

The purpose of this study was to evaluate the effects of
the HEART Camp intervention on adherence to exercise,
physical function, and patient-reported outcomes in the subgroups of adults with HFpEF and HFrEF as compared with
enhanced usual care. In the HFpEF subgroup, adherence
was significantly greater at 12 (42.9% vs 14.3%) and 18
(56% vs 0%) months in the HEART Camp intervention
group compared with enhanced usual care. Physical function also improved significantly (based on 6MWT distances) over time in the HEART Camp group compared with
enhanced usual care counterparts. Patient-reported outcomes, including heart failure-related health status (KCCQ
Overall Summary Score), symptoms (KCCQ, Total Symptom Score), and clinical health status (KCCQ Clinical Summary Score) were also statistically and clinically significant
when comparing HEART Camp to enhanced usual care.
These findings are critically important given the limited
successful treatment approaches in HFpEF. Our HFrEF subgroup did not achieve significant differences in adherence,
physical function, or patient-reported outcomes aside from
improvements in anxiety in the HEART Camp intervention
group compared with enhanced usual care over time. This
article is the first to report long-term adherence outcomes
out to 18 months and the first to report sustained improvement in health status from 12 to 18 months in an exercise
trial in adults with HFpEF.
Difficulties with initiation and continued adherence to
exercise have plagued adults with HF, as well as HF clinicians. HF-ACTION, the largest study of exercise in HF to
date, included only participants with reduced ejection fraction and reported adherence to the target of 120 minutes per
week at 12 months to be 35%.16,37 In our parent study of
HEART Camp, we enrolled adults with stable chronic HF
and adherence was similar at 42% in the intervention group
at 12 months compared with 19% in the enhanced usual
care group.17
Interventions such as financial incentives have been used
to successfully encourage short-term (<6 months) participation in exercise or standard cardiac rehabilitation programs.38 However, studies of long-term exercise programs
or exercise adherence are limited with little data to inform
effective intervention strategies. To date, Optimex-Clin is
the only completed longer term (12-month) trial focused on
adults with HFpEF. Investigators in the Optimex-Clin trial
defined adherence as 70% or greater attendance at sessions.
Using this definition, the trial’s moderate continuous training (comparable with the HEART Camp moderate intensity
aerobic training) achieved 60.4% adherence when considering the full 12-month study, which is similar to the adherence we achieved in our HFpEF subgroup of 56% at 18
months. When Optimex-Clin investigators considered the
home-based portion of the intervention (months 4 12)
alone, adherence was 58.5%.10 In the recent REHAB-HF
trial, adherence was high; however, adherence was measured by session attendance during the intervention period
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and by patient self-report in the follow-up period.14 Each of
these surrogates for adherence is difficult to validate.
Important to note is that the definition of adherence in
HEART Camp was based on minutes of validated, moderate
intensity exercise (defined as achieving 40% 80% of heart
rate reserve). These differences in adherence definitions
and measurements contribute to the difficulty of comparing
adherence across studies. Establishing a standard definition
of adherence is critical to enhancing intertrial comparisons
in the future and should be made a priority by clinicians and
exercise scientists, particularly in HFpEF where a largescale clinical trial has yet to be undertaken. Without standardization, adherence will remain the perpetual Achille’s
heel of exercise programs in HF.2
Adults with HFpEF in our HEART Camp group
responded more favorably than enhanced usual care peers
in terms of physical function improvements as measured by
6MWT distances at 18 months. The findings were not only
statistically significant (P = .048), but also associated with a
positive and moderate change in clinical status. These
results are consistent with short-term studies of exercise
interventions with HFpEF.5,6 Maldonado-Martin et al5
reported significant improvements in 6MWT distances in
an exercise training group vs attention-control in a 16-week
exercise intervention trial. This intervention also improved
ventilatory thresholds and peak oxygen consumption, but
these outcomes were not significantly correlated with
improvements in the 6MWT.5 Caloric restriction in combination with exercise have been reported to work synergistically to improve 6MWT distance in HFpEF.6 Physical
function and health status continued to improve over time
for adults with HFpEF in the HEART Camp intervention
group. These improvements may have contributed to the
observed increase in adherence seen between 12 and 18
months.
Interestingly, we did not find significant differences in
adherence or most patient-reported outcomes when comparing HEART Camp with enhanced usual care in our HFrEF
subgroup. This factor suggests that the findings reported in
our primary outcome report were highly influenced by
adherence in the HFpEF subgroup.22 It is unclear whether
these adherence findings were driven by differing pathophysiological and/or symptom profiles in HFpEF and
HFrEF or disparate responses to exercise that led to
improved adherence among those with HFpEF. Our findings are consistent with a subgroup analysis of REHABHF, in which older adults with HFpEF responded more
favorably to the intervention than HFrEF counterparts.39 In
their analyses, adults with HFpEF responded favorably with
large effect sizes on the short physical performance battery,
the KCCQ, and 6MWT distance. Adherence was similar
across HFpEF and HFrEF subgroups during the intervention
and at follow-up. However, as noted elsewhere in this article, adherence was defined based on session attendance and
patient self-report, which may not correspond with objectively measured minutes of moderate intensity exercise.
Taken together, these findings support the potential

usefulness of the HEART Camp intervention to promote
adherence to exercise in adults with HFpEF and, ultimately,
improve patient-reported outcomes in this population.
Several prior exercise interventions trials in HFpEF have
tested intervention effects on quality of life and health status outcomes.6,8,13,40 These trials have reported significant
improvements in the physical domains of both the Shortform-36 and the Minnesota Living with Heart Failure Questionnaire after supervised aerobic and/or resistance training
interventions.40,41 In this subgroup analysis, participants in
the intervention group reported a significantly greater
change over time in their KCCQ overall summary, clinical
summary, and total symptom scores compared with
enhanced usual care. To date, 1 shorter term (20 weeks)
study6 and 1 longer term (12 months) study, OptimexClin10 have used the KCCQ to test exercise effects on
health status in HFpEF. Interestingly, Kitzman et al6
reported that, in a trial of a caloric restriction intervention
compared with and combined with exercise, caloric restriction alone improved KCCQ scores, but exercise did not.
These findings may have resulted from the short-term intervention of only 20 weeks. Comparatively, our findings and
the findings of Optimex-Clin over 12 months showed that,
although initially the scores may be similar across intervention and control groups, over the long-term health status (as
measured with the KCCQ) does seem to improve with exercise interventions.10
We tested interventional effects on symptoms using the
PROMIS-29. We did not record significant changes
between the groups in our HFpEF subgroup. This study is
the first reported to examine change in specific symptoms
in a trial of exercise in adults with HFpEF aside from
depression. Prior studies have demonstrated that improvements in depression may be achieved with exercise interventions in adults with HFpEF.13,40 Although we did not
find significant changes here, we did note trends in improvement. Future fully powered studies are needed to see if
these trends would reach significance. In our HFrEF subgroup, the HEART Camp intervention group reported significantly greater improvements in anxiety compared with
enhanced usual care counterparts.
We would like to acknowledge the limitations of this study.
This analysis is a retrospective, subgroup analysis from a parent
study. Therefore, findings should not be generalized beyond
this sample. We recruited from 2 sites in the United States,
namely, Detroit, Michigan, and Lincoln, Nebraska. Despite the
small number of sites, our sample was representative relative to
race and biological sex across groups. Further, we used a consistent interventional protocol at both sites and closely monitored
intervention fidelity as published previously.42 We noted no differences in the intervention effects between sites and believe
that our intervention has a high potential for translation. We
acknowledge that, overall, our sample was younger and
included more men than typically reported in the general
HFpEF population. In the parent study, randomization occurred
after a run-in period, which further limits the generalizability of
our findings. The run-in period allowed for monitored exercise
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sessions and equipment orientation before independent exercise
to decrease the risk of participant injury or adverse events.
Future studies may incorporate a stratified sampling approach
to further diversify the sample.
Conclusions
The findings of these subgroup analyses are highly
encouraging, and additional research on alternative, costconscious delivery methods and a larger clinical trial of our
multicomponent intervention to test long-term adherence in
adults with HFpEF is warranted. Exercise remains one of
few treatment strategies to successfully promote positive
outcomes in adults with HFpEF. To further drive these
improvements, interventions to support long-term adherence are critical.
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